Mercks Belzutifan Approved for Treating VHL-Related Cancers
| CDAZX Fund | USD 8.30 0.02 0.24% |
Slightly above 54% of Multi-manager Directional's investor base is interested to short. The analysis of overall sentiment of trading Multi Manager Directional Alternative mutual fund suggests that many investors are impartial at this time. Multi-manager Directional's investing sentiment can be driven by a variety of factors including economic data, Multi-manager Directional's earnings reports, geopolitical events, and overall market trends.
Multi-manager |
The National Medical Products Administration has approved Mercks Belzutifan tablets for the treatment of von Hippel-Lindau disease-associated renal
Read at gurufocus.com
 |
Multi-manager Directional Fundamental Analysis
We analyze Multi-manager Directional's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Multi-manager Directional using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Multi-manager Directional based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Multi Manager is currently under evaluation in total asset among similar funds. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Multi-manager Directional Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Multi-manager Directional mutual fund to make a market-neutral strategy. Peer analysis of Multi-manager Directional could also be used in its relative valuation, which is a method of valuing Multi-manager Directional by comparing valuation metrics with similar companies.
Peers
Multi-manager Directional Related Equities
| SRINX | Columbia Porate | 0.44 | ||||
| CUURX | Columbia Small | 0.44 | ||||
| CUTYX | Columbia | 0.30 | ||||
| CUTRX | Columbia Treasury | 0.30 | ||||
| CDDRX | Columbia Dividend | 0.16 | ||||
| CDDYX | Columbia Dividend | 0.16 | ||||
| CUSBX | Columbia Ultra | 0.00 | ||||
| CUSHX | Columbia Ultra | 0.00 | ||||
| CUVRX | Columbia | 0.00 |
Other Information on Investing in Multi-manager Mutual Fund
Multi-manager Directional financial ratios help investors to determine whether Multi-manager Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Multi-manager with respect to the benefits of owning Multi-manager Directional security.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |